1,131
Views
8
CrossRef citations to date
0
Altmetric
Review

Rituximab in immunologic glomerular diseases

, , &
Pages 198-207 | Received 23 Nov 2011, Accepted 07 Jan 2012, Published online: 01 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yining Zhao, Yumei Li, Xiaoqiong Wu, Li Li, Jiayu Liu, Yanlan Wang, Yue Liu, Qing Li & Zhong Wang. (2020) Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies. Cancer Biology & Therapy 21:1, pages 72-80.
Read now

Articles from other publishers (7)

Lucia Del Vecchio, Marco Allinovi, Paolo Rocco & Bruno Brando. (2021) Rituximab Therapy for Adults with Nephrotic Syndromes: Standard Schedules or B Cell-Targeted Therapy?. Journal of Clinical Medicine 10:24, pages 5847.
Crossref
WanJun Lu, ShuHao Gong, Juan Li, HongWen Luo & Ying Wang. (2020) Efficacy and safety of rituximab in the treatment of membranous nephropathy. Medicine 99:16, pages e19804.
Crossref
Samira Farouk & Jonathan Winston. 2019. Kidney Protection. Kidney Protection 227 C23.P62 .
Alice Bonanni, Marta Calatroni, Matteo D'Alessandro, Sara Signa, Enrica Bertelli, Michela Cioni, Eddi Di Marco, Roberto Biassoni, Gianluca Caridi, Giulia Ingrasciotta, Roberta Bertelli, Armando Di Donato, Maurizio Bruschi, Alberto Canepa, Giorgio Piaggio, Pietro Ravani & Gian Marco Ghiggeri. (2018) Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome. British Journal of Clinical Pharmacology 84:6, pages 1238-1249.
Crossref
Wisit Cheungpasitporn, Stephen L. Kopecky, Ulrich Specks, Kharmen Bharucha & Fernando C. Fervenza. (2016) Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy. Journal of Renal Injury Prevention 6:1, pages 18-25.
Crossref
Bonny L. Dickinson. (2016) Unraveling the immunopathogenesis of glomerular disease. Clinical Immunology 169, pages 89-97.
Crossref
Aditi Sinha & Arvind Bagga. (2013) Rituximab therapy in nephrotic syndrome: implications for patients' management. Nature Reviews Nephrology 9:3, pages 154-169.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.